Skip to main content
. 2021 Jan 27;10(3):473. doi: 10.3390/jcm10030473
As evidence for its benefit is lacking, prophylactic mastectomy is currently not recommended for female PJS patients. Risk reducing mastectomy should be discussed in a multidisciplinary setting also taking into account family history and other clinical factors.
Level of evidence: low
Strength of recommendation: moderate